These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8905401)

  • 1. Anti-fucosyl-GM1 ganglioside IgG and IgM autoantibodies in human serum: no link to pathology.
    Adler G; Pacuszka T; Strugalska M; Targońska I; Panasiewicz M; Lewartowska A
    Immunol Lett; 1996 Sep; 52(2-3):89-93. PubMed ID: 8905401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolipids noncovalently bound to DEAE-Sephadex. Use of the complexes for purification of IgM and IgG anti-(Gal beta 1-->3 GalNAc-) antibodies.
    Rodriguez PE; Barra JL; Cumar FA
    Biochem Mol Biol Int; 1994 May; 33(2):273-81. PubMed ID: 7524899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside reactive antibodies of IgG and IgM class in sera of patients with differentiated thyroid cancer.
    Lewartowska A; Pacuszka T; Adler G; Panasiewicz M; Wojciechowska W
    Immunol Lett; 2002 Feb; 80(2):129-32. PubMed ID: 11750045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells.
    Quattrini A; Lorenzetti I; Sciorati C; Corbo M; Previtali SC; Feltri ML; Canal N; Wrabetz L; Nemni R; Clementi E
    J Neuroimmunol; 2001 Mar; 114(1-2):213-9. PubMed ID: 11240034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental presence of antibodies against gangliosides in Graves' disease.
    Adler G; Pacuszka T; Targonska I; Lewartowska A; Nauman J
    Autoimmunity; 1994; 18(2):149-52. PubMed ID: 7742477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell lung cancer is not associated with the presence of anti-fucosyl-GM1 ganglioside autoantibodies reactive in immunoenzymatic test.
    Adler G; Pacuszka T; Lewartowska A; Rowinska E; Oblakowski P; Panasiewicz M
    Lung Cancer; 2001 Dec; 34(3):383-5. PubMed ID: 11714535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
    Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
    Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-GM1 ganglioside antibodies in Parkinson's disease.
    Zappia M; Crescibene L; Bosco D; Arabia G; Nicoletti G; Bagalà A; Bastone L; Napoli ID; Caracciolo M; Bonavita S; Di Costanzo A; Gambardella A; Quattrone A
    Acta Neurol Scand; 2002 Jul; 106(1):54-7. PubMed ID: 12067330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
    Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC
    Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?
    Bartolomei F; Boucraut J; Barrié M; Kok J; Dravet C; Viallat D; Bernard D; Gastaut JL
    Epilepsia; 1996 Oct; 37(10):922-6. PubMed ID: 8822688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
    Bech E; Jakobsen J; Orntoft TF
    Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.
    Lardone RD; Yuki N; Irazoqui FJ; Nores GA
    Sci Rep; 2016 Jan; 6():19901. PubMed ID: 26818965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to fucogangliosides in neurological diseases.
    Yuki N; Ariga T
    J Neurol Sci; 1997 Sep; 150(1):81-4. PubMed ID: 9260862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.